2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)

C209H180N21O2Pd5S2-15 — CID 157235865

IUPAC2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)
SMILESCCCCC(CCCC)(c1[c-]c2c(cc1)Oc1ccccc1N2c1[c-]c(N2[CH-]N(C)c3ccccc32)ccc1)c1ccccn1.CN1C=CN(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6ccccc6C(C)(C)c6ccccc65)ccc4Oc4ccccc43)ccc2)[CH-]1.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)CCCC5)ccc4Sc4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)CCCCC5)ccc4Sc4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6cc(C(C)(C)C)ccc6-c6ccc(C(C)(C)C)cc65)ccc4N(C)c4ccccc43)ccc2)c2ccccc21.[Pd].[Pd].[Pd].[Pd].[Pd]
InChIInChI=1S/C53H48N5.C43H33N4O.C40H39N4O.C37H31N4S.C36H29N4S.5Pd/c1-51(2,3)35-23-26-40-41-27-24-36(52(4,5)6)31-43(41)53(42(40)30-35,50-22-13-14-29-54-50)37-25-28-46-49(32-37)58(48-21-12-10-19-45(48)56(46)8)39-17-15-16-38(33-39)57-34-55(7)44-18-9-11-20-47(44)57;1-42(2)33-15-4-6-17-35(33)43(41-21-10-11-24-44-41,36-18-7-5-16-34(36)42)30-22-23-40-38(27-30)47(37-19-8-9-20-39(37)48-40)32-14-12-13-31(28-32)46-26-25-45(3)29-46;1-4-6-24-40(25-7-5-2,39-21-12-13-26-41-39)30-22-23-38-36(27-30)44(35-19-10-11-20-37(35)45-38)32-16-14-15-31(28-32)43-29-42(3)33-17-8-9-18-34(33)43;1-39-26-40(31-15-4-3-14-30(31)39)28-12-11-13-29(25-28)41-32-16-5-6-17-34(32)42-35-20-19-27(24-33(35)41)37(21-8-2-9-22-37)36-18-7-10-23-38-36;1-38-25-39(30-14-3-2-13-29(30)38)27-11-10-12-28(24-27)40-31-15-4-5-16-33(31)41-34-19-18-26(23-32(34)40)36(20-7-8-21-36)35-17-6-9-22-37-35;;;;;/h9-31,34H,1-8H3;4-26,29H,1-3H3;8-23,26,29H,4-7,24-25H2,1-3H3;3-7,10-20,23,26H,2,8-9,21-22H2,1H3;2-6,9-19,22,25H,7-8,20-21H2,1H3;;;;;/q5*-3;;;;;
InChIKeyFBFMGUFRQTTXBA-UHFFFAOYSA-N
MW3614.12 g/mol
LogP51.90
Rot. Bonds26

About 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)

2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium) (PubChem CID 157235865) has the molecular formula C209H180N21O2Pd5S2-15 and a molecular weight of 3614.12 g/mol. Its IUPAC name is 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium).

Molecular Properties

Compound Name2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)
PubChem CID157235865
Molecular FormulaC209H180N21O2Pd5S2-15
Molecular Weight3614.12 g/mol
Exact Mass3608.93
IUPAC Name2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)
SMILESCCCCC(CCCC)(c1[c-]c2c(cc1)Oc1ccccc1N2c1[c-]c(N2[CH-]N(C)c3ccccc32)ccc1)c1ccccn1.CN1C=CN(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6ccccc6C(C)(C)c6ccccc65)ccc4Oc4ccccc43)ccc2)[CH-]1.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)CCCC5)ccc4Sc4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)CCCCC5)ccc4Sc4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6cc(C(C)(C)C)ccc6-c6ccc(C(C)(C)C)cc65)ccc4N(C)c4ccccc43)ccc2)c2ccccc21.[Pd].[Pd].[Pd].[Pd].[Pd]
InChIInChI=1S/C53H48N5.C43H33N4O.C40H39N4O.C37H31N4S.C36H29N4S.5Pd/c1-51(2,3)35-23-26-40-41-27-24-36(52(4,5)6)31-43(41)53(42(40)30-35,50-22-13-14-29-54-50)37-25-28-46-49(32-37)58(48-21-12-10-19-45(48)56(46)8)39-17-15-16-38(33-39)57-34-55(7)44-18-9-11-20-47(44)57;1-42(2)33-15-4-6-17-35(33)43(41-21-10-11-24-44-41,36-18-7-5-16-34(36)42)30-22-23-40-38(27-30)47(37-19-8-9-20-39(37)48-40)32-14-12-13-31(28-32)46-26-25-45(3)29-46;1-4-6-24-40(25-7-5-2,39-21-12-13-26-41-39)30-22-23-38-36(27-30)44(35-19-10-11-20-37(35)45-38)32-16-14-15-31(28-32)43-29-42(3)33-17-8-9-18-34(33)43;1-39-26-40(31-15-4-3-14-30(31)39)28-12-11-13-29(25-28)41-32-16-5-6-17-34(32)42-35-20-19-27(24-33(35)41)37(21-8-2-9-22-37)36-18-7-10-23-38-36;1-38-25-39(30-14-3-2-13-29(30)38)27-11-10-12-28(24-27)40-31-15-4-5-16-33(31)41-34-19-18-26(23-32(34)40)36(20-7-8-21-36)35-17-6-9-22-37-35;;;;;/h9-31,34H,1-8H3;4-26,29H,1-3H3;8-23,26,29H,4-7,24-25H2,1-3H3;3-7,10-20,23,26H,2,8-9,21-22H2,1H3;2-6,9-19,22,25H,7-8,20-21H2,1H3;;;;;/q5*-3;;;;;
InChIKeyFBFMGUFRQTTXBA-UHFFFAOYSA-N
XLogP51.90
TPSA134.75 Ų
H-Bond Donors
H-Bond Acceptors25
Rotatable Bonds26
Heavy Atoms239
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003614.12
LogP ≤ 551.90
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1025

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)?
The IUPAC name of 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium) (CID 157235865) is 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium).
What is the SMILES notation for 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)?
The canonical SMILES for 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium) is CCCCC(CCCC)(c1[c-]c2c(cc1)Oc1ccccc1N2c1[c-]c(N2[CH-]N(C)c3ccccc32)ccc1)c1ccccn1.CN1C=CN(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6ccccc6C(C)(C)c6ccccc65)ccc4Oc4ccccc43)ccc2)[CH-]1.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)CCCC5)ccc4Sc4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)CCCCC5)ccc4Sc4ccccc43)ccc2)c2ccccc21.CN1[CH-]N(c2[c-]c(N3c4[c-]c(C5(c6ccccn6)c6cc(C(C)(C)C)ccc6-c6ccc(C(C)(C)C)cc65)ccc4N(C)c4ccccc43)ccc2)c2ccccc21.[Pd].[Pd].[Pd].[Pd].[Pd].
What is the InChIKey of 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)?
The InChIKey is FBFMGUFRQTTXBA-UHFFFAOYSA-N. The full InChI is InChI=1S/C53H48N5.C43H33N4O.C40H39N4O.C37H31N4S.C36H29N4S.5Pd/c1-51(2,3)35-23-26-40-41-27-24-36(52(4,5)6)31-43(41)53(42(40)30-35,50-22-13-14-29-54-50)37-25-28-46-49(32-37)58(48-21-12-10-19-45(48)56(46)8)39-17-15-16-38(33-39)57-34-55(7)44-18-9-11-20-47(44)57;1-42(2)33-15-4-6-17-35(33)43(41-21-10-11-24-44-41,36-18-7-5-16-34(36)42)30-22-23-40-38(27-30)47(37-19-8-9-20-39(37)48-40)32-14-12-13-31(28-32)46-26-25-45(3)29-46;1-4-6-24-40(25-7-5-2,39-21-12-13-26-41-39)30-22-23-38-36(27-30)44(35-19-10-11-20-37(35)45-38)32-16-14-15-31(28-32)43-29-42(3)33-17-8-9-18-34(33)43;1-39-26-40(31-15-4-3-14-30(31)39)28-12-11-13-29(25-28)41-32-16-5-6-17-34(32)42-35-20-19-27(24-33(35)41)37(21-8-2-9-22-37)36-18-7-10-23-38-36;1-38-25-39(30-14-3-2-13-29(30)38)27-11-10-12-28(24-27)40-31-15-4-5-16-33(31)41-34-19-18-26(23-32(34)40)36(20-7-8-21-36)35-17-6-9-22-37-35;;;;;/h9-31,34H,1-8H3;4-26,29H,1-3H3;8-23,26,29H,4-7,24-25H2,1-3H3;3-7,10-20,23,26H,2,8-9,21-22H2,1H3;2-6,9-19,22,25H,7-8,20-21H2,1H3;;;;;/q5*-3;;;;;.
What are the key properties of 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium)?
2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium) has a molecular weight of 3614.12 g/mol, XLogP of 51.90, 26 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)-5-methyl-10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)-10-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclohexyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(1-pyridin-2-ylcyclopentyl)-1H-phenothiazin-1-ide;10-[3-(3-methyl-2H-benzimidazol-2-id-1-yl)benzene-2-id-1-yl]-2-(5-pyridin-2-ylnonan-5-yl)-1H-phenoxazin-1-ide;pentakis(palladium) is sourced from PubChem (CID 157235865), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).